Stocks and Investing
Stocks and Investing
Thu, April 16, 2020
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Annabel Samimy Maintained (TXMD) at Strong Buy with Increased Target to $750 on, Apr 16th, 2020
Annabel Samimy of Stifel, Maintained "TherapeuticsMD, Inc." (TXMD) at Strong Buy with Increased Target from $700 to $750 on, Apr 16th, 2020.
Annabel has made no other calls on TXMD in the last 4 months.
There is 1 other peer that has a rating on TXMD. Out of the 1 peers that are also analyzing TXMD, 0 agree with Annabel's Rating of Hold.
This is the rating of the analyst that currently disagrees with Annabel
- Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $300 on, Friday, February 21st, 2020